COL4A1 and porencephaly: In addition, with a high de novo mutation rate of 40%, 21 COL4A1 (12 of them novel) and 3 COL4A2 pathogenic mutations were identified, mostly in children with porencephaly or other patterns of parenchymal hemorrhage [124].